Kaiser To Fund Gun Injury Research
Three research studies will focus on how clinicians can help prevent firearm injuries.
Kaiser Permanente, the nation's largest nonprofit, integrated health system, will fund three clinical research studies related to gun injury research.
The clinical research studies that focus on how clinicians can help prevent firearm injuries, including suicide, intimate partner violence, and accidents, as part of its pledge to invest $2 million to prevent gun injuries and deaths.
The studies will be led by investigators at three of Kaiser Permanente's regional research institutes in partnership with its Permanente Medical Group clinicians and physicians.
The studies are:
- Understanding Risk Factors of Firearm-related Injuries and Death in Adult and Pediatric Populations: Risk Prediction and Opportunities for Prevention. This study builds on existing work in Kaiser Permanente Washington that involves screening patients who are receiving mental health-related care for access to firearms.
Related: Surprising Perceptions About Mental Health
- Evaluating a Web-Based Education Tool for Safe Firearm Storage in Patients at Risk for Suicide. This study will focus on patients who report suicidality during medical or mental health visits. It will test the impact of an anonymous, web-based decision aid for safe firearm storage as an adjunctive approach to existing provider-delivered interventions.
- Understanding Risk Factors of Firearm-related Injuries and Death in Adult and Pediatric Populations: Risk Prediction and Opportunities for Prevention. This study will develop a risk prediction model for both intentional and unintentional firearm-related injuries leveraging data from Kaiser Permanente Southern California and community-level data. It will also generate a heatmap of high-risk communities to inform strategies for firearm injury prevention interventions at the medical center and clinic level.
In 2018, Kaiser Permanente announced the formation of its Firearm Injury Prevention Task Force and an accompanying $2 million research fund to address preventable gun-related injuries and death.
Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent
June 19th 2025Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be available to the people who would benefit most from HIV PrEP?
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
